Trial intelligence / Profile preview

Metformin and sirtuin gene expression in obese children and adolescents

IRCT201104164585N4Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metformin in obesity, sponsored by Iran University of Medical Sciences. Primary endpoint: Change in sirtuin gene expression. Started May 2016; status: completed.

02

Drugs

metformin
03

Conditions

obesity

Beyond the preview

Go deeper on IRCT201104164585N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201104164585N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call